nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—RET—autonomic nervous system—attention deficit hyperactivity disorder	0.0457	0.0769	CbGeAlD
Regorafenib—NTRK1—midbrain—attention deficit hyperactivity disorder	0.0176	0.0296	CbGeAlD
Regorafenib—DDR2—cardiovascular system—attention deficit hyperactivity disorder	0.0168	0.0282	CbGeAlD
Regorafenib—DDR2—nervous system—attention deficit hyperactivity disorder	0.0108	0.0181	CbGeAlD
Regorafenib—DDR2—central nervous system—attention deficit hyperactivity disorder	0.0104	0.0174	CbGeAlD
Regorafenib—FLT4—cardiovascular system—attention deficit hyperactivity disorder	0.0102	0.0172	CbGeAlD
Regorafenib—MAPK11—nervous system—attention deficit hyperactivity disorder	0.0102	0.0172	CbGeAlD
Regorafenib—FGFR2—forebrain—attention deficit hyperactivity disorder	0.0101	0.017	CbGeAlD
Regorafenib—DDR2—cerebellum—attention deficit hyperactivity disorder	0.0101	0.017	CbGeAlD
Regorafenib—MAPK11—central nervous system—attention deficit hyperactivity disorder	0.00982	0.0165	CbGeAlD
Regorafenib—MAPK11—cerebellum—attention deficit hyperactivity disorder	0.0096	0.0161	CbGeAlD
Regorafenib—RAF1—forebrain—attention deficit hyperactivity disorder	0.00933	0.0157	CbGeAlD
Regorafenib—BRAF—midbrain—attention deficit hyperactivity disorder	0.00925	0.0156	CbGeAlD
Regorafenib—PDGFRA—forebrain—attention deficit hyperactivity disorder	0.00879	0.0148	CbGeAlD
Regorafenib—FGFR2—cardiovascular system—attention deficit hyperactivity disorder	0.00856	0.0144	CbGeAlD
Regorafenib—EPHA2—cardiovascular system—attention deficit hyperactivity disorder	0.00841	0.0142	CbGeAlD
Regorafenib—DDR2—brain—attention deficit hyperactivity disorder	0.00822	0.0138	CbGeAlD
Regorafenib—TEK—cardiovascular system—attention deficit hyperactivity disorder	0.00821	0.0138	CbGeAlD
Regorafenib—FLT1—cardiovascular system—attention deficit hyperactivity disorder	0.00794	0.0133	CbGeAlD
Regorafenib—KDR—forebrain—attention deficit hyperactivity disorder	0.00793	0.0133	CbGeAlD
Regorafenib—RAF1—cardiovascular system—attention deficit hyperactivity disorder	0.00789	0.0133	CbGeAlD
Regorafenib—FGFR1—midbrain—attention deficit hyperactivity disorder	0.00786	0.0132	CbGeAlD
Regorafenib—MAPK11—brain—attention deficit hyperactivity disorder	0.00779	0.0131	CbGeAlD
Regorafenib—PDGFRA—cardiovascular system—attention deficit hyperactivity disorder	0.00744	0.0125	CbGeAlD
Regorafenib—BRAF—cerebellum—attention deficit hyperactivity disorder	0.00715	0.012	CbGeAlD
Regorafenib—RET—midbrain—attention deficit hyperactivity disorder	0.00704	0.0118	CbGeAlD
Regorafenib—EPHX2—cerebellum—attention deficit hyperactivity disorder	0.00684	0.0115	CbGeAlD
Regorafenib—KDR—cardiovascular system—attention deficit hyperactivity disorder	0.00671	0.0113	CbGeAlD
Regorafenib—TEK—midbrain—attention deficit hyperactivity disorder	0.00641	0.0108	CbGeAlD
Regorafenib—FLT1—midbrain—attention deficit hyperactivity disorder	0.0062	0.0104	CbGeAlD
Regorafenib—RAF1—midbrain—attention deficit hyperactivity disorder	0.00616	0.0104	CbGeAlD
Regorafenib—FGFR1—cerebellum—attention deficit hyperactivity disorder	0.00608	0.0102	CbGeAlD
Regorafenib—KIT—cardiovascular system—attention deficit hyperactivity disorder	0.00595	0.01	CbGeAlD
Regorafenib—BRAF—brain—attention deficit hyperactivity disorder	0.00581	0.00977	CbGeAlD
Regorafenib—PDGFRB—cardiovascular system—attention deficit hyperactivity disorder	0.00581	0.00977	CbGeAlD
Regorafenib—RET—nervous system—attention deficit hyperactivity disorder	0.00579	0.00973	CbGeAlD
Regorafenib—RET—central nervous system—attention deficit hyperactivity disorder	0.00557	0.00937	CbGeAlD
Regorafenib—EPHX2—brain—attention deficit hyperactivity disorder	0.00555	0.00934	CbGeAlD
Regorafenib—FGFR2—nervous system—attention deficit hyperactivity disorder	0.0055	0.00925	CbGeAlD
Regorafenib—RET—cerebellum—attention deficit hyperactivity disorder	0.00544	0.00916	CbGeAlD
Regorafenib—EPHA2—nervous system—attention deficit hyperactivity disorder	0.0054	0.00909	CbGeAlD
Regorafenib—FGFR2—central nervous system—attention deficit hyperactivity disorder	0.00529	0.0089	CbGeAlD
Regorafenib—TEK—nervous system—attention deficit hyperactivity disorder	0.00527	0.00886	CbGeAlD
Regorafenib—KDR—midbrain—attention deficit hyperactivity disorder	0.00524	0.00881	CbGeAlD
Regorafenib—EPHA2—central nervous system—attention deficit hyperactivity disorder	0.0052	0.00875	CbGeAlD
Regorafenib—ABL1—cardiovascular system—attention deficit hyperactivity disorder	0.00518	0.00871	CbGeAlD
Regorafenib—FGFR2—cerebellum—attention deficit hyperactivity disorder	0.00517	0.0087	CbGeAlD
Regorafenib—FLT1—nervous system—attention deficit hyperactivity disorder	0.0051	0.00857	CbGeAlD
Regorafenib—TEK—central nervous system—attention deficit hyperactivity disorder	0.00507	0.00853	CbGeAlD
Regorafenib—RAF1—nervous system—attention deficit hyperactivity disorder	0.00507	0.00852	CbGeAlD
Regorafenib—FLT4—brain—attention deficit hyperactivity disorder	0.00501	0.00842	CbGeAlD
Regorafenib—TEK—cerebellum—attention deficit hyperactivity disorder	0.00496	0.00834	CbGeAlD
Regorafenib—FGFR1—brain—attention deficit hyperactivity disorder	0.00494	0.00831	CbGeAlD
Regorafenib—FLT1—central nervous system—attention deficit hyperactivity disorder	0.00491	0.00825	CbGeAlD
Regorafenib—RAF1—central nervous system—attention deficit hyperactivity disorder	0.00488	0.0082	CbGeAlD
Regorafenib—FLT1—cerebellum—attention deficit hyperactivity disorder	0.00479	0.00806	CbGeAlD
Regorafenib—PDGFRA—nervous system—attention deficit hyperactivity disorder	0.00477	0.00803	CbGeAlD
Regorafenib—RAF1—cerebellum—attention deficit hyperactivity disorder	0.00477	0.00802	CbGeAlD
Regorafenib—KIT—midbrain—attention deficit hyperactivity disorder	0.00464	0.00781	CbGeAlD
Regorafenib—PDGFRA—central nervous system—attention deficit hyperactivity disorder	0.0046	0.00773	CbGeAlD
Regorafenib—PDGFRB—midbrain—attention deficit hyperactivity disorder	0.00453	0.00763	CbGeAlD
Regorafenib—PDGFRA—cerebellum—attention deficit hyperactivity disorder	0.00449	0.00756	CbGeAlD
Regorafenib—RET—brain—attention deficit hyperactivity disorder	0.00442	0.00744	CbGeAlD
Regorafenib—KDR—nervous system—attention deficit hyperactivity disorder	0.00431	0.00724	CbGeAlD
Regorafenib—FGFR2—brain—attention deficit hyperactivity disorder	0.0042	0.00707	CbGeAlD
Regorafenib—KDR—central nervous system—attention deficit hyperactivity disorder	0.00415	0.00697	CbGeAlD
Regorafenib—EPHA2—brain—attention deficit hyperactivity disorder	0.00413	0.00695	CbGeAlD
Regorafenib—KDR—cerebellum—attention deficit hyperactivity disorder	0.00405	0.00682	CbGeAlD
Regorafenib—ABL1—midbrain—attention deficit hyperactivity disorder	0.00404	0.0068	CbGeAlD
Regorafenib—TEK—brain—attention deficit hyperactivity disorder	0.00403	0.00678	CbGeAlD
Regorafenib—FLT1—brain—attention deficit hyperactivity disorder	0.00389	0.00655	CbGeAlD
Regorafenib—RAF1—brain—attention deficit hyperactivity disorder	0.00387	0.00651	CbGeAlD
Regorafenib—KIT—nervous system—attention deficit hyperactivity disorder	0.00382	0.00642	CbGeAlD
Regorafenib—PDGFRB—nervous system—attention deficit hyperactivity disorder	0.00373	0.00627	CbGeAlD
Regorafenib—KIT—central nervous system—attention deficit hyperactivity disorder	0.00367	0.00618	CbGeAlD
Regorafenib—PDGFRA—brain—attention deficit hyperactivity disorder	0.00365	0.00614	CbGeAlD
Regorafenib—KIT—cerebellum—attention deficit hyperactivity disorder	0.00359	0.00604	CbGeAlD
Regorafenib—PDGFRB—central nervous system—attention deficit hyperactivity disorder	0.00359	0.00604	CbGeAlD
Regorafenib—PDGFRB—cerebellum—attention deficit hyperactivity disorder	0.00351	0.0059	CbGeAlD
Regorafenib—ABL1—nervous system—attention deficit hyperactivity disorder	0.00332	0.00559	CbGeAlD
Regorafenib—KDR—brain—attention deficit hyperactivity disorder	0.00329	0.00554	CbGeAlD
Regorafenib—ABL1—central nervous system—attention deficit hyperactivity disorder	0.0032	0.00538	CbGeAlD
Regorafenib—ABL1—cerebellum—attention deficit hyperactivity disorder	0.00313	0.00526	CbGeAlD
Regorafenib—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00301	0.00506	CbGeAlD
Regorafenib—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00298	0.00502	CbGeAlD
Regorafenib—KIT—brain—attention deficit hyperactivity disorder	0.00292	0.00491	CbGeAlD
Regorafenib—PDGFRB—brain—attention deficit hyperactivity disorder	0.00285	0.00479	CbGeAlD
Regorafenib—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00255	0.00429	CbGeAlD
Regorafenib—ABL1—brain—attention deficit hyperactivity disorder	0.00254	0.00427	CbGeAlD
Regorafenib—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00197	0.00332	CbGeAlD
Regorafenib—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00193	0.00325	CbGeAlD
Regorafenib—ABCB1—forebrain—attention deficit hyperactivity disorder	0.0019	0.0032	CbGeAlD
Regorafenib—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00186	0.00313	CbGeAlD
Regorafenib—CYP2C8—brain—attention deficit hyperactivity disorder	0.00165	0.00277	CbGeAlD
Regorafenib—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00161	0.00271	CbGeAlD
Regorafenib—ABCG2—brain—attention deficit hyperactivity disorder	0.0016	0.00269	CbGeAlD
Regorafenib—CYP2B6—brain—attention deficit hyperactivity disorder	0.00148	0.00249	CbGeAlD
Regorafenib—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00146	0.00246	CbGeAlD
Regorafenib—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00141	0.00236	CbGeAlD
Regorafenib—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00126	0.00211	CbGeAlD
Regorafenib—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00103	0.00174	CbGeAlD
Regorafenib—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000995	0.00167	CbGeAlD
Regorafenib—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000972	0.00164	CbGeAlD
Regorafenib—ABCB1—brain—attention deficit hyperactivity disorder	0.00079	0.00133	CbGeAlD
Regorafenib—PDGFRA—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000277	0.000682	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000276	0.000682	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000275	0.000679	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000272	0.000671	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000271	0.000669	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000264	0.000651	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000262	0.000647	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000261	0.000645	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000261	0.000644	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000261	0.000643	CbGpPWpGaD
Regorafenib—BRAF—Disease—SNAP25—attention deficit hyperactivity disorder	0.000258	0.000637	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000254	0.000627	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000249	0.000615	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000248	0.000612	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000244	0.000603	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000242	0.000596	CbGpPWpGaD
Regorafenib—FGFR2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000239	0.00059	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000236	0.000583	CbGpPWpGaD
Regorafenib—KIT—Disease—SNAP25—attention deficit hyperactivity disorder	0.000235	0.00058	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000228	0.000563	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000228	0.000562	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000227	0.000559	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000225	0.000554	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000225	0.000554	CbGpPWpGaD
Regorafenib—FGFR1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000223	0.00055	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000223	0.000549	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—SNAP25—attention deficit hyperactivity disorder	0.000222	0.000549	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000222	0.000548	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000218	0.000537	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000218	0.000536	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000214	0.000527	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000212	0.000523	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000212	0.000522	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000211	0.000521	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000207	0.000512	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000206	0.000509	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000206	0.000507	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000205	0.000506	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000203	0.000499	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000202	0.000498	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000202	0.000497	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—SNAP25—attention deficit hyperactivity disorder	0.0002	0.000494	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.0002	0.000492	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000199	0.000491	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000197	0.000485	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000196	0.000484	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000196	0.000483	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000194	0.00048	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000193	0.000475	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000192	0.000474	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000192	0.000474	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000192	0.000474	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000192	0.000474	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000192	0.000474	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000192	0.000473	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000191	0.000472	CbGpPWpGaD
Regorafenib—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00019	0.000469	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000189	0.000467	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000189	0.000467	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000186	0.000458	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000185	0.000457	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000183	0.00045	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000181	0.000446	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00018	0.000445	CbGpPWpGaD
Regorafenib—RAF1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000179	0.000441	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000178	0.00044	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000177	0.000437	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000177	0.000436	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000176	0.000434	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000176	0.000434	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000175	0.000432	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000174	0.000429	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000173	0.000428	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000173	0.000426	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000172	0.000424	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000172	0.000423	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00017	0.000419	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000169	0.000417	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000168	0.000414	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000168	0.000413	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000168	0.000413	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000165	0.000406	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000163	0.000403	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000163	0.000403	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000162	0.0004	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000161	0.000396	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00016	0.000394	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00016	0.000393	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000159	0.000393	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000158	0.000391	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000158	0.000389	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000158	0.000388	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000157	0.000386	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000156	0.000385	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000156	0.000384	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000155	0.000382	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000154	0.00038	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000154	0.000379	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000154	0.000379	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000153	0.000376	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000151	0.000373	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000151	0.000372	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000151	0.000372	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000149	0.000368	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000149	0.000367	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000148	0.000366	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000147	0.000362	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000147	0.000362	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000147	0.000362	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000146	0.000361	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000146	0.000361	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000146	0.000361	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000145	0.000357	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000144	0.000355	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000142	0.00035	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00014	0.000346	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000139	0.000343	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000138	0.00034	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000137	0.000337	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000136	0.000337	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000136	0.000335	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000135	0.000332	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000135	0.000332	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000134	0.000332	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000134	0.000331	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000134	0.00033	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000134	0.00033	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000132	0.000325	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000131	0.000323	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000131	0.000323	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00013	0.000322	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00013	0.000321	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00013	0.00032	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000128	0.000315	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000125	0.000309	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000124	0.000306	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000123	0.000304	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000123	0.000303	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000122	0.000301	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000121	0.000299	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000121	0.000299	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.00012	0.000296	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00012	0.000295	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00012	0.000295	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000119	0.000295	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.000294	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000118	0.000291	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000118	0.00029	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000118	0.00029	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000117	0.000287	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000117	0.000287	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000116	0.000285	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000116	0.000285	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000112	0.000277	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000112	0.000276	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000111	0.000274	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00011	0.00027	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000109	0.00027	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000108	0.000266	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000104	0.000256	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000103	0.000254	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000101	0.00025	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000101	0.00025	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000101	0.000249	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	9.97e-05	0.000246	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	9.89e-05	0.000244	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.82e-05	0.000242	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.58e-05	0.000236	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.57e-05	0.000236	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.56e-05	0.000236	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.26e-05	0.000228	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—EP300—attention deficit hyperactivity disorder	9.17e-05	0.000226	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.11e-05	0.000225	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	9.04e-05	0.000223	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.04e-05	0.000223	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	8.9e-05	0.000219	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	8.82e-05	0.000218	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.82e-05	0.000218	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	8.68e-05	0.000214	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.61e-05	0.000212	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—EP300—attention deficit hyperactivity disorder	8.42e-05	0.000208	CbGpPWpGaD
Regorafenib—BRAF—Disease—EP300—attention deficit hyperactivity disorder	8.39e-05	0.000207	CbGpPWpGaD
Regorafenib—KIT—Immune System—EP300—attention deficit hyperactivity disorder	8.27e-05	0.000204	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.27e-05	0.000204	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	8.24e-05	0.000203	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.24e-05	0.000203	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	8.11e-05	0.0002	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.1e-05	0.0002	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.07e-05	0.000199	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.88e-05	0.000194	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—EP300—attention deficit hyperactivity disorder	7.85e-05	0.000194	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—EP300—attention deficit hyperactivity disorder	7.83e-05	0.000193	CbGpPWpGaD
Regorafenib—FGFR2—Disease—EP300—attention deficit hyperactivity disorder	7.78e-05	0.000192	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.71e-05	0.00019	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.67e-05	0.000189	CbGpPWpGaD
Regorafenib—KIT—Disease—EP300—attention deficit hyperactivity disorder	7.64e-05	0.000188	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.54e-05	0.000186	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.3e-05	0.00018	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	7.25e-05	0.000179	CbGpPWpGaD
Regorafenib—FGFR1—Disease—EP300—attention deficit hyperactivity disorder	7.25e-05	0.000179	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—EP300—attention deficit hyperactivity disorder	7.23e-05	0.000178	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.23e-05	0.000178	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.2e-05	0.000178	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—EP300—attention deficit hyperactivity disorder	7.06e-05	0.000174	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.05e-05	0.000174	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.9e-05	0.00017	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.88e-05	0.00017	CbGpPWpGaD
Regorafenib—ABL1—Immune System—EP300—attention deficit hyperactivity disorder	6.88e-05	0.00017	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.72e-05	0.000166	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.59e-05	0.000163	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—EP300—attention deficit hyperactivity disorder	6.51e-05	0.000161	CbGpPWpGaD
Regorafenib—RAF1—Immune System—EP300—attention deficit hyperactivity disorder	6.29e-05	0.000155	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.27e-05	0.000155	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	6.14e-05	0.000151	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	6.09e-05	0.00015	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.93e-05	0.000146	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.91e-05	0.000146	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.88e-05	0.000145	CbGpPWpGaD
Regorafenib—RAF1—Disease—EP300—attention deficit hyperactivity disorder	5.81e-05	0.000143	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	5.48e-05	0.000135	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.45e-05	0.000134	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	5.44e-05	0.000134	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.44e-05	0.000134	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.44e-05	0.000134	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.35e-05	0.000132	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.35e-05	0.000132	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	5.35e-05	0.000132	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.31e-05	0.000131	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.27e-05	0.00013	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.08e-05	0.000125	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.06e-05	0.000125	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	5e-05	0.000123	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—EP300—attention deficit hyperactivity disorder	5e-05	0.000123	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	4.99e-05	0.000123	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.97e-05	0.000123	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	4.96e-05	0.000122	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.81e-05	0.000119	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.56e-05	0.000112	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.35e-05	0.000107	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	4.24e-05	0.000105	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.14e-05	0.000102	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.07e-05	0.0001	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.29e-05	8.12e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.27e-05	8.07e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	3.11e-05	7.67e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	2.63e-05	6.49e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.35e-05	5.79e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.29e-05	5.65e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.14e-05	5.28e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.41e-05	3.48e-05	CbGpPWpGaD
